mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
SARS-CoV-2 mRNA vaccines have shown remarkable efficacy, especially in preventing severe illness and hospitalization. However, the emergence of several variants of concern and reports of declining antibody levels have raised uncertainty about the durability of immune memory following vaccination. In this study, we longitudinally profiled both antibody and cellular immune responses in SARS-CoV-2 naïve and recovered individuals from pre-vaccine baseline to 6 months post-mRNA vaccination. Antibody and neutralizing titers decayed from peak levels but remained detectable in all subjects at 6 months post-vaccination. Functional memory B cell responses, including those specific for the receptor binding domain (RBD) of the Alpha (B.1.1.7), Beta (B.1.351), and Delta (B.1.617.2) variants, were also efficiently generated by mRNA vaccination and continued to increase in frequency between 3 and 6 months post-vaccination. Notably, most memory B cells induced by mRNA vaccines were capable of cross-binding variants of concern, and B cell receptor sequencing revealed significantly more hypermutation in these RBD variant-binding clones compared to clones that exclusively bound wild-type RBD. Moreover, the percent of variant cross-binding memory B cells was higher in vaccinees than individuals who recovered from mild COVID-19. mRNA vaccination also generated antigen-specific CD8+ T cells and durable memory CD4+ T cells in most individuals, with early CD4+ T cell responses correlating with humoral immunity at later timepoints. These findings demonstrate robust, multi-component humoral and cellular immune memory to SARS-CoV-2 and current variants of concern for at least 6 months after mRNA vaccination. Finally, we observed that boosting of pre-existing immunity with mRNA vaccination in SARS-CoV-2 recovered individuals primarily increased antibody responses in the short-term without significantly altering antibody decay rates or long-term B and T cell memory. Together, this study provides insights into the generation and evolution of vaccine-induced immunity to SARS-CoV-2, including variants of concern, and has implications for future booster strategies. GRAPHICAL ABSTRACT:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · cited 5×
“Community-level immunity, acquired through natural infection or vaccination, is necessary to control the pandemic as the virus continues to circulate ( 1 ). mRNA vaccines encoding a stabilized version of the full-length SARS-CoV-2 Spike protein are being widely administered and clinical trial data demonstrate up to 95…”
MethodInfluentialEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2021) · Science · doi:10.1126/science.abf4063 · Cited by 2,656
Self-citationEffector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865
Self-citationImmune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Gilbert, P. B., Montefiori, D. C., McDermott, A. B., Fong, Y., Benkeser, D., Deng, W., Zhou, H., Houchens, C. R., Martins, K., Jayashankar, L., et al. (2022) · Science · doi:10.1126/science.abm3425 · Cited by 1,137
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Pallesen, J., Wang, N., Corbett, K. S., Wrapp, D., Kirchdoerfer, R. N., Turner, H. L., Cottrell, C. A., Becker, M. M., Wang, L., Shi, W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707304114 · Cited by 1,073
Human memory T cells: generation, compartmentalization and homeostasis
Farber, D. L., Yudanin, N. A., & Restifo, N. P. (2014) · Nature Reviews Immunology · doi:10.1038/nri3567 · Cited by 897
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Wang, Z., Muecksch, F., Schaefer-Babajew, D., Finkin, S., Viant, C., Gaebler, C., Hoffmann, H. H., Barnes, C. O., Cipolla, M., Ramos, V., et al. (2021) · Nature · doi:10.1038/s41586-021-03696-9 · Cited by 721
Tarke, A., Sidney, J., Kidd, C. K., Dan, J. M., Ramirez, S. I., Yu, E. D., Mateus, J., da Silva Antunes, R., Moore, E., Rubiro, P., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100204 · Cited by 540
Self-citationGeers, D., Shamier, M. C., Bogers, S., den Hartog, G., Gommers, L., Nieuwkoop, N. N., Schmitz, K. S., Rijsbergen, L. C., van Osch, J. A. T., Dijkhuizen, E., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj1750 · Cited by 529
Research works printed but not linked: 42
- T. Carvalho , F. Krammer , A. Iwasaki , The first 12 months of COVID-19: a timeline of immunological insights. Nat. Rev. Immunol., 1–12 (2021). · DOI · Paper page
- 10.1038/s41591-021-01377-8 · DOI · Paper page
- 10.1101/2021.08.11.21261876 · DOI
- 10.1101/2021.08.09.21261290 · DOI
- N. Doria-Rose , M. S. Suthar , M. Makowski , S. O’Connell , A. B. McDermott , B. Flach , J. E. Ledgerwood , J. R. Mascola , B. S. Graham , B. C. Lin , S. O’Dell , S. D. Schmidt , A. T. Widge , V.-V. Edara , E. J. Anderson , L. Lai , K. Floyd , N. G. Rouphael , V. Zarnitsyna , P. C. Roberts , M. Makhene , W. Buchanan , C. J. Luke , J. H. Beigel , L. A. Jackson , K. M. Neuzil , H. Bennett , B. Leav , J. Albert , P. Kunwar , mRNA-1273 Study Group, Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19. N. Engl. J. Med., NEJMc2103916 (2021). · DOI · Paper page
- 10.1056/NEJMOA2109072 · DOI · Paper page
- 10.1101/2021.08.03.21261496 · DOI
- 10.1101/2021.07.28.21261159 · DOI · Paper page
- 2021, SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses, Nat, 2021, 1
- 2021, Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination, Sci. Immunol, 6, 1
- 10.1101/2021.07.29.454333 · DOI · Paper page
- 10.1016/J.IMMUNI.2021.08.001 · DOI · Paper page
- 10.1016/J.XCRM.2021.100355 · DOI · Paper page
- 10.1101/2021.06.30.21259787 · DOI · Paper page
- 2021, Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection, Nat. Rev. Immunol, 21, 395, 10.1038/s41577-021-00550-x · DOI · Paper page
- 10.1038/s41577-019-0244-2 · DOI · Paper page
- 10.1101/2021.08.20.21262158 · DOI · Paper page
- 2021, Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells, Cell Reports Med, 2, 100354, 10.1016/j.xcrm.2021.100354 · DOI · Paper page
- D. A. Collier , A. De Marco , I. A. T. M. Ferreira , B. Meng , R. Datir , A. C. Walls , S. A. Kemp S , J. Bassi , D. Pinto , C. S. Fregni , S. Bianchi , M. A. Tortorici , J. Bowen , K. Culap , S. Jaconi , E. Cameroni , G. Snell , M. S. Pizzuto , A. F. Pellanda , C. Garzoni , A. Riva , A. Elmer , N. Kingston , B. Graves , L. E. McCoy , K. G. C. Smith , J. R. Bradley , N. Temperton , L. Lourdes Ceron-Gutierrez , G. Barcenas-Morales , W. Harvey , H. W. Virgin , A. Lanzavecchia , L. Piccoli , R. Doffinger , M. Wills , D. Veesler , D. Corti , R. K. Gupta , Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature, 1–8 (2021). · DOI · Paper page
- 2021, Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera, Cell, 189, 1
- 10.1016/J.CELL.2021.06.020 · DOI · Paper page
- 10.1016/j.cell.2021.03.013 · DOI · Paper page
- L. Stamatatos , J. Czartoski , Y.-H. Wan , L. J. Homad , V. Rubin , H. Glantz , M. Neradilek , E. Seydoux , M. F. Jennewein , A. J. MacCamy , J. Feng , G. Mize , S. C. De Rosa , A. Finzi , M. P. Lemos , K. W. Cohen , Z. Moodie , M. J. McElrath , A. T. McGuire , mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection. Science (80-.)., eabg9175 (2021). · DOI · Paper page
- 10.1126/science.abh1282 · DOI · Paper page
- 10.1038/ni.3533 · DOI · Paper page
- 10.1016/j.jim.2013.02.009 · DOI
- S. Gouma , M. E. Weirick , M. J. Bolton , C. P. Arevalo , E. C. Goodwin , E. M. Anderson , C. M. McAllister , S. R. Christensen , D. Dunbar , D. Fiore , A. Brock , J. Weaver , J. S. Millar , S. DerOhannessian , I. Frank , D. J. Rader , E. J. Wherry , S. E. Hensley , Health care worker sero-monitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration. JCI Insight, 446 (2021). · DOI
- 10.1126/science.abe1107 · DOI · Paper page
- 10.1128/mBio.00939-20 · DOI · Paper page
- 2020, SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness, Nat, 586, 567, 10.1038/s41586-020-2622-0 · DOI · Paper page
- 10.1038/S41467-021-24123-7 · DOI · Paper page
- D. HL, S. CT, L. L, C. S, A. NW, H. PJ, Z. NY, H. M, S. DG, C. MS, E. SA, G. JJ, S. O, W. J, W. ES, M. ML, S. K, J. MO, A. F, S. I, U. HA, H. J, N. CA, D. YN, H. PD, J. RP, J. A, K. F, D. MS, F. DH, K. Y, W. PC, 2021, Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets, Immunity, 54, 1290, 10.1016/j.immuni.2021.05.001 · DOI · Paper page
- 10.3389/fimmu.2018.01472 · DOI · Paper page
- C. Gaebler , Z. Wang , J. C. C. Lorenzi , F. Muecksch , S. Finkin , M. Tokuyama , A. Cho , M. Jankovic , D. Schaefer-Babajew , T. Y. Oliveira , M. Cipolla , C. Viant , C. O. Barnes , Y. Bram , G. Breton , T. Hägglöf , P. Mendoza , A. Hurley , M. Turroja , K. Gordon , K. G. Millard , V. Ramos , F. Schmidt , Y. Weisblum , D. Jha , M. Tankelevich , G. Martinez-Delgado , J. Yee , R. Patel , J. Dizon , C. Unson-O’Brien , I. Shimeliovich , D. F. Robbiani , Z. Zhao , A. Gazumyan , R. E. Schwartz , T. Hatziioannou , P. J. Bjorkman , S. Mehandru , P. D. Bieniasz , M. Caskey , M. C. Nussenzweig , Evolution of antibody immunity to SARS-CoV-2. Nature, 1–6 (2021). · DOI
- 10.1126/SCIIMMUNOL.ABD5709 · DOI · Paper page
- 10.1038/nbt.3942 · DOI · Paper page
- 10.1126/sciimmunol.abd7114 · DOI · Paper page
- 10.1093/bioinformatics/btu138 · DOI · Paper page
- 10.1093/nar/gkt382 · DOI · Paper page
- 10.1093/bioinformatics/btw593 · DOI
- 2018, ImmuneDB, a Novel Tool for the Analysis, Storage, and Dissemination of Immune Repertoire Sequencing Data, Front. Immunol, 9, 2107, 10.3389/fimmu.2018.02107 · DOI · Paper page
- 10.1093/molbev/msw046 · DOI · Paper page
Cited by
Tarke, A., Coelho, C. H., Zhang, Z., Dan, J. M., Yu, E. D., Methot, N., Bloom, N. I., Goodwin, B., Phillips, E., Mallal, S., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.015 · Cited by 858
Self-citationCOVID vaccine immunity is waning — how much does that matter?
Dolgin, E. (2021) · Nature · doi:10.1038/d41586-021-02532-4 · Cited by 123
Chu, L., Montefiori, D., Huang, W., Nestorova, B., Chang, Y., Carfi, A., Edwards, D. K., Oestreicher, J., Legault, H., Girard, B., et al. (2021) · doi:10.1101/2021.09.29.21264089 · Cited by 105
Metadata
- Authors
- Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., Gouma, S., Kuri-Cervantes, L., Hicks, P., Dysinger, S., Hicks, A., Sharma, H., Herring, S., Korte, S., Baxter, A. E., Oldridge, D. A., Giles, J. R., Weirick, M. E., McAllister, C. M., Awofolaju, M., Tanenbaum, N., Drapeau, E. M., Dougherty, J., Long, S., D’Andrea, K., Hamilton, J. T., McLaughlin, M., Williams, J. C., Adamski, S., Kuthuru, O., Unit, T. U. C. P., Frank, I., Betts, M. R., Vella, L. A., Grifoni, A., Weiskopf, D., Sette, A., Hensley, S. E., Davenport, M. P., Bates, P., Luning Prak, E. T., Greenplate, A. R., & Wherry, E. J.
- Venue
- bioRxiv (Cold Spring Harbor Laboratory)
- Publisher
- openRxiv
- Published
- 2021-08-23
- OpenAlex
- W3194838263
- Cited by
- 59
- References
- 15
- Type
- posted content
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern. https://app.cochat.ai/papers/10.1101/2021.08.23.457229
- The paper
- Goel, R. R., Painter, M. M., Apostolidis, S. A., Mathew, D., Meng, W., Rosenfeld, A. M., Lundgreen, K. A., Reynaldi, A., Khoury, D. S., Pattekar, A., Gouma, S., Kuri-Cervantes, L., Hicks, P., Dysinger, S., Hicks, A., Sharma, H., Herring, S., Korte, S., Baxter, A. E., . . . Wherry, E. J. (2021). mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2021.08.23.457229
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.